It was an all-Texas affair at the U.S. Court of Appeals for the Federal Circuit on Tuesday as lawyers from Vinson & Elkins, Baker Botts and Skiermont Derby hashed out a patent dispute that poses novel issues of sovereign immunity.

Skiermont Derby’s Paul Skiermont argued to the D.C.-based appellate court that the University of Texas had unfairly granted his client, Gensetix Inc., the right to license a cancer treatment developed at the university, but then refused to join in a suit against alleged infringers at the Baylor College of Medicine.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]